Skip to Main Content
Skip Nav Destination

The development of successful laboratory testing directed towards the identification of brain biomarkers in biological fluids is presented in this chapter. Highlighted is a roadmap for immunoassays measuring antigens–peptides and antibodies to assess brain injury. The choice of unique reagents, assay design, and platform is described in order to build laboratory and point-of-care tests with high performance characteristics.

You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal